Abraham Ceesay, President at Cerevel Therapeutics Holdings, Inc. (CERE), sold 19,210 shares at $32.50 ($624K) on 2022-09-08, disclosed to the SEC on 2022-09-12.
Open-market sale of $624k CERE by President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RAPP | SELL | 2026-08-26 | $938K | — | Filing → |
| RAPP | SELL | 2026-08-12 | $2.4M | — | Filing → |
| RAPP | SELL | 2026-07-29 | $93K | — | Filing → |